Chris M. Kaster founded Alhambra Medical, Inc. and 33 BioMedical, Inc. Currently, Mr. Kaster is Chief Executive Officer & Director at Alhambra Medical, Inc. and Chief Executive Officer & Director at 33 BioMedical, Inc. Mr. Kaster is also on the board of Aesthera Corp., Alleviant Medical, Inc. and Medicus Sciences Acquisition Corp.

In the past Mr. Kaster held the position of Principal at General Mills, Inc., Member of MedVenture Associates, Senior Equity Research Analyst at WR Hambrecht + Co. LLC and Equity Research Analyst at U.S. Bancorp Piper Jaffray Ventures.

Chris M. Kaster received an undergraduate degree from St. Olaf College and an MBA from The Curtis L. Carlson School of Management.